Scarica l'app Stockscreener
8.085
0.87%
0.025
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Menopause Treatment Market Opportunities, Challenges, - openPR
What is B. Riley's Estimate for Novavax FY2024 Earnings? - MarketBeat
Novavax to Present at Jefferies London Conference - TipRanks
Preventive Vaccines Market May Set New Growth Story | Takeda - openPR
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
How To Trade (NVAX) - Stock Traders Daily
FY2024 Earnings Forecast for Novavax Issued By HC Wainwright - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices
UK regulator approves adapted Novavax jab - The Pharma Letter
Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post
Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times
Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance
Novavax Grants Stock Options, RSUs to New R&D Chief in Executive Compensation Deal | NVAX Stock News - StockTitan
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - MSN
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance
Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com
Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Stock Experiences Significant Drop Amid Industry Volatility - GuruFocus.com
Protein-based Vaccine Sales Strategy Advances - Precision Vaccinations
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Stock Market Increases While Tesla And Novavax Take A Hit - Finimize
Novavax CEO to Present at Jefferies Healthcare Conference in London | NVAX Stock News - StockTitan
Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic P - GuruFocus.com
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Novavax Advances Vaccine Strategy Amid Financial Shifts - TipRanks
Earnings call: Novavax outlines strategic growth and partnership with Sanofi - Investing.com
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax (NVAX) Reports Q3 Loss, Tops Revenue Estimates - MSN
Novavax Becomes Oversold (NVAX) - Nasdaq
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals [Video] - AOL
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better - The Business Journals
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals - Yahoo Finance
Novavax to Report Q3 Earnings: Here's What to Expect - MSN
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine - Yahoo! Voices
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls - AOL
Novavax Resumes Phase 3 Vaccine Trials After FDA Hold - TipRanks
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):